Price: $116.51
· 1 day: +1.60% · 5 days: -14.17% · 1 month: -1.75% · YTD: +52.34%
As of 2026-11-03 21:00 UTC.
52-week range: $42.25 – $139.92 (currently at 76% of the range).
RBRK is in an uptrend, momentum soft. $125 is the level overhead; $111.12 the first support below.
3 of 6 technical checks lean bullish.
| Trend | Uptrend · above 50-day & 200-day |
|---|---|
| Momentum | RSI 52.26 · neutral · MACD bearish |
| Trend strength | ADX 19.9 · weak or range |
| Location | +4.8% vs 50-day MA |
| 52-week range | -14% from high · +166% from low |
| Volatility | ATR 8.52 · ~7.3%/day |
| Level | Type | Distance |
|---|---|---|
| $125.0 (resistance) | round | 7.29% |
| $136.0 (resistance) | 52w high | 16.73% |
| $150.0 (resistance) | round | 28.74% |
| $111.12 (support) | sma 50 | -4.63% |
| $106.44 (support) | swing zone | -8.64% |
| $100.0 (support) | round | -14.17% |
| RSI (14) | 52.26 | MACD | 3.3566 |
|---|---|---|---|
| ADX (14) | 19.9 | ATR (14) | 8.52 |
| 50-day average | $111.12 | 200-day average | $77.11 |
Next earnings: 2026-12-03. RBRK earnings date, time and past reactions.
Report of 2026-10-28, updated 2026-11-02.
Rubrik (RBRK) has fallen 12.1% over the past five sessions, closing at $117.28 on November 2, 2026, after a sharp pullback from its October 28 peak of $136.00. The decline accelerated on November 2 with a 5.5% drop, while the broader market (SPY -0.6%) and sector (XLK -2.0%) were relatively stable, indicating stock-specific selling pressure. The stock remains 6.8% ahead of the S&P 500 and 11.9% ahead of XLK over the past 50 days, and it still trades above its 40-week average.
The picture holds. The bullish stance from the October 28 report remains intact, with the stock above its 50-day SMA at $110.81 and the long-term uptrend confirmed by the 40-week average. The key support level has moved slightly lower: the swing zone that would end the trend is now $106.44 (previously $106.81), and a weekly close below that would change the picture. Resistance stands at $125.00 (round number) and the 52-week high of $136.00, with $150.00 as the next major target. The RSI at 48.97 suggests neutral momentum, and volume is 90.5% below its 20-day average, indicating low participation in the recent decline.
Analyst sentiment remains supportive: Morgan Stanley initiated coverage with an overweight rating and a $155 target on October 29, and the consensus is a strong buy with a mean target of $122.46. Historically, one-day drops of more than 5% have led to higher prices a month later in 70.9% of cases, with a median gain of 5.4%. The next earnings report is scheduled for December 3, 2026.
Rubrik (RBRK) closed at $135.74 on October 27, 2026, a 52-week high, after gaining 18.5% in five days with no news in the data to explain the move. The stock sits above both its 10-week and 40-week averages and is outrunning the S&P 500 and the technology sector by wide margins. The balance of evidence leans positive with high conviction, though a breakout from here offers thin reward for the risk.
There is no event to point to. The news feed for RBRK is empty: no earnings release, no analyst action, no deal, no sector headline. The stock rose 1.8% on the day and 18.5% over five days, and nothing in the record accounts for that. A move this size without a catalyst usually means positioning or a sector rotation that has not been reported. Either way, the reader should treat the cause as unexplained rather than assume one.
The 5-day split shows how much of the move belongs to the stock. The S&P 500 (SPY) gained 0.08% over those five days and the technology sector ETF (XLK) gained 2.2%. RBRK's 18.5% therefore left it about 16.3 points ahead of its sector. The market contributed almost nothing and the sector a little, so this was overwhelmingly stock-specific buying. The longer record points the same way. Over one month RBRK is up 23.9% while SPY is down 0.2% and XLK is down 3.5%. Over 50 days it leads SPY by 24.7 points and XLK by 25.2 points. The stock is up 154.9% in six months and 77.5% year to date.
With no articles to cite, the debate can only be drawn from the analyst data, not from named arguments. The bull side is visible in the consensus: 27 analysts, rated strong buy, with price targets from $110 to $150. The cautious side is in the same numbers. The mean target is $121.26, and the stock trades 11.9% above it. Only the highest target, $150, sits above the current price. Buyers have pushed the shares past what the average analyst models, and the stock's market value of about $27.9 billion already reflects much of the good news. The stock is either ahead of its estimates or the estimates are behind the stock. The data do not say which.
The long-term thesis is intact, and the stock is in an advanced uptrend. It sits above its 40-week average, well above the 200-day average at $75.72 and the 50-day average at $108.55. It trades 209.8% above its 52-week low of $43.81 and exactly at its 52-week high. The assessment from October 28, 2026 was bullish with high conviction and a trend-ending level of $106.81 on a weekly close. Nothing since then has damaged that: the trend, the leadership and the level are all as they were. The reading is unchanged.
Over the next 2 to 6 weeks the balance of evidence leans positive, and conviction is high at 3 of 4 points. Three things support it: the daily trend runs with the weekly uptrend, the stock leads the S&P 500 by 24.7 points over 50 days, and it leads XLK by 25.2 points. The RSI is 61.4, so the stock is strong but not stretched into overbought territory.
The strongest case against is the volume. Volume on the latest session was 22.3% below its 20-day average, so the new high came on thinner participation than usual. Combined with an 18.5% five-day jump and no news behind it, that raises the chance of a pause or a pullback toward $125. The stock is also 11.9% above the mean analyst target. This is why conviction is not higher. It does not tip the balance because the trend, the relative strength and the position above every key average are all intact, and light volume on one day is a warning rather than a break.
The structure holds above $125, a round number just under the recent run. A close below it would be the first crack, and it would likely mean the surge is being partly given back. The 50-day average at $108.55 and the swing zone at $106.81 sit below that. The trend ends below $106.81, a level set by prior swing lows. It matters on a weekly close, since a single day through it would not change the weekly trend. $100 and $86.08 are the next supports beyond that.
The breakout level is a daily close above $150 on volume above its 20-day average. The upside target is $175, another round number. The stop, where a breakout would be wrong, is $123.24, which is $125 less a quarter of the 14-day average true range. From $150 that math gives 0.9 to 1: less than a dollar of reward for each dollar at risk. It does not reach the 3 to 1 that makes a breakout worth the risk. A far higher target than $175 would be needed, or a much closer stop. Neither exists on the current map.
The rule is a weekly close below $106.81, the swing zone that marks the end of the uptrend. The non-price fact that would most likely cause it is a growth disappointment in company results or guidance, since a stock valued above its analyst targets depends on growth continuing. Such news would turn an 18% run into an unwind and remove the support that the weekly trend and relative strength now provide.
Interactive RBRK chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs